• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice.与 CD4 和 CD8 T 细胞共生的细胞毒性巨噬细胞在 NOD 小鼠中阻断 PD-1 后会导致急性糖尿病。
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31319-31330. doi: 10.1073/pnas.2019743117. Epub 2020 Nov 23.
2
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.人脂肪间充质干细胞预防免疫检查点阻断诱导的 1 型糖尿病。
Diabetologia. 2022 Jul;65(7):1185-1197. doi: 10.1007/s00125-022-05708-3. Epub 2022 May 5.
3
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells.程序性细胞死亡受体 1 阻断在小鼠黑色素瘤同基因模型中需要共刺激、CD4 和 CD8 T 细胞。
Cancer Immunol Res. 2016 Oct;4(10):845-857. doi: 10.1158/2326-6066.CIR-16-0060. Epub 2016 Sep 2.
4
Mouse pancreatic beta cells express MHC class II and stimulate CD4(+) T cells to proliferate.鼠胰岛β细胞表达 MHC Ⅱ类分子,并刺激 CD4(+)T 细胞增殖。
Eur J Immunol. 2015 Sep;45(9):2494-503. doi: 10.1002/eji.201445378. Epub 2015 May 28.
5
A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.一种缺失的 PD-L1/PD-1 共抑制作用以表位特异性方式调节前胰岛素特异性 CD8 T 细胞诱导的糖尿病。
PLoS One. 2013 Aug 19;8(8):e71746. doi: 10.1371/journal.pone.0071746. eCollection 2013.
6
Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.基质 PD-L1 阳性调节性 T 细胞和 PD-1 阳性 CD8 阳性 T 细胞定义了不同亚组非小细胞肺癌对 PD-1/PD-L1 阻断免疫治疗的反应。
J Thorac Oncol. 2018 Apr;13(4):521-532. doi: 10.1016/j.jtho.2017.11.132. Epub 2017 Dec 18.
7
Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.通过 PD-1/PD-L1 轴抑制胆管癌细胞中的 T 细胞介导的免疫反应。
Eur J Pharmacol. 2021 Apr 15;897:173960. doi: 10.1016/j.ejphar.2021.173960. Epub 2021 Feb 19.
8
Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.前沿:鉴定对程序性死亡受体1(PD-1)通路阻断有抗性的自身反应性CD4+和CD8+T细胞亚群
J Immunol. 2015 Apr 15;194(8):3551-3555. doi: 10.4049/jimmunol.1402262. Epub 2015 Mar 13.
9
PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.短暂抗TCRβ单克隆抗体治疗后,NOD糖尿病小鼠模型中依赖PD-1的自身耐受性恢复。
Diabetologia. 2015 Jun;58(6):1309-18. doi: 10.1007/s00125-015-3564-1. Epub 2015 Mar 21.
10
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.强制表达程序性死亡受体 1 基因可降低 1 型糖尿病的发病率。
Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3. Epub 2010 Nov 30.

引用本文的文献

1
Type I Diabetes-A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection.1型糖尿病——接受免疫治疗患者中描述的一种罕见不良事件与SARS-CoV-2感染的一种副作用。
Reports (MDPI). 2025 Mar 14;8(1):31. doi: 10.3390/reports8010031.
2
Adipose-derived mesenchymal stromal/stem cells in type 1 diabetes treatment.1型糖尿病治疗中的脂肪来源间充质基质/干细胞
Commun Biol. 2025 Jul 23;8(1):1094. doi: 10.1038/s42003-025-08244-z.
3
Polyfunctional T follicular helper cells drive checkpoint-inhibitor diabetes and are targeted by JAK inhibitor therapy.多功能滤泡辅助性T细胞驱动检查点抑制剂糖尿病,并成为JAK抑制剂疗法的作用靶点。
JCI Insight. 2025 Jul 8;10(13). doi: 10.1172/jci.insight.188843.
4
Gluten-Free Diet Induces Small-Scale Changes Across Multiple T-Cell Subsets in NOD Mice.无麸质饮食在非肥胖糖尿病(NOD)小鼠的多个T细胞亚群中诱导小规模变化。
Eur J Immunol. 2025 Apr;55(4):e202451559. doi: 10.1002/eji.202451559.
5
Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors.西米普利单抗与糖尿病酮症酸中毒:一例与免疫检查点抑制剂相关的罕见内分泌病病例报告
Front Endocrinol (Lausanne). 2025 Mar 25;16:1550702. doi: 10.3389/fendo.2025.1550702. eCollection 2025.
6
Tissue Resident and Infiltrating Immune Cells: Their Influence on the Demise of Beta Cells in Type 1 Diabetes.组织驻留和浸润性免疫细胞:它们对1型糖尿病中β细胞死亡的影响
Biomolecules. 2025 Mar 19;15(3):441. doi: 10.3390/biom15030441.
7
TCL1A in naïve B cells as a therapeutic target for type 1 diabetes.初始B细胞中的TCL1A作为1型糖尿病的治疗靶点。
EBioMedicine. 2025 Mar;113:105593. doi: 10.1016/j.ebiom.2025.105593. Epub 2025 Feb 12.
8
UTX Epigenetically Imposes a Cytolytic Effector Program in Autoreactive Stem-like CD8+ T cell Progenitors.UTX通过表观遗传方式在自身反应性干细胞样CD8 + T细胞祖细胞中施加溶细胞效应程序。
bioRxiv. 2024 Dec 20:2024.12.12.628206. doi: 10.1101/2024.12.12.628206.
9
Polyfunctional IL-21 IFNG T follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy.多功能白细胞介素-21干扰素γ辅助性滤泡T细胞导致检查点抑制剂糖尿病,可通过JAK抑制剂疗法进行靶向治疗。
bioRxiv. 2024 Dec 3:2024.11.27.625710. doi: 10.1101/2024.11.27.625710.
10
TGF-β-mediated crosstalk between TIGIT Tregs and CD226CD8 T cells in the progression and remission of type 1 diabetes.TGF-β 介导的 TIGIT Tregs 和 CD226CD8 T 细胞在 1 型糖尿病进展和缓解中的串扰。
Nat Commun. 2024 Oct 15;15(1):8894. doi: 10.1038/s41467-024-53264-8.

本文引用的文献

1
TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy.TREM2 调控重塑肿瘤髓系免疫微环境增强抗 PD-1 免疫治疗。
Cell. 2020 Aug 20;182(4):886-900.e17. doi: 10.1016/j.cell.2020.07.013. Epub 2020 Aug 11.
2
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.单细胞 RNA 测序和细胞内蛋白活性分析揭示 TREM2 在癌症中的免疫抑制作用。
Cell. 2020 Aug 20;182(4):872-885.e19. doi: 10.1016/j.cell.2020.06.032. Epub 2020 Aug 11.
3
Single-cell RNA sequencing of murine islets shows high cellular complexity at all stages of autoimmune diabetes.单细胞 RNA 测序显示,在自身免疫性糖尿病的所有阶段,胰岛具有高度的细胞复杂性。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20192362.
4
Beta cell-specific CD8 T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes.胰岛β细胞特异性 CD8 T 细胞在 1 型糖尿病中维持与干细胞记忆相关的表观遗传程序。
Nat Immunol. 2020 May;21(5):578-587. doi: 10.1038/s41590-020-0633-5. Epub 2020 Mar 30.
5
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.PD-L1 与 T 细胞的结合促进了自身耐受性,并抑制了癌症中相邻的巨噬细胞和效应 T 细胞。
Nat Immunol. 2020 Apr;21(4):442-454. doi: 10.1038/s41590-020-0620-x. Epub 2020 Mar 9.
6
The MHC-II peptidome of pancreatic islets identifies key features of autoimmune peptides.胰岛的 MHC-II 肽组鉴定出自身免疫肽的关键特征。
Nat Immunol. 2020 Apr;21(4):455-463. doi: 10.1038/s41590-020-0623-7. Epub 2020 Mar 9.
7
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α.抗程序性死亡蛋白1(PD-1)免疫疗法通过肿瘤坏死因子-α(TNF-α)的失调导致结核病复发。
Elife. 2020 Feb 24;9:e52668. doi: 10.7554/eLife.52668.
8
PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.在持续的 LCMV 感染期间,PD-1+ 类干细胞 CD8 T 细胞存在于淋巴组织中。
Proc Natl Acad Sci U S A. 2020 Feb 25;117(8):4292-4299. doi: 10.1073/pnas.1917298117. Epub 2020 Feb 7.
9
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.免疫检查点抑制剂相关性糖尿病:一种新型自身免疫性糖尿病。
Clin Exp Immunol. 2020 May;200(2):131-140. doi: 10.1111/cei.13424. Epub 2020 Feb 28.
10
Targeted deletion of PD-1 in myeloid cells induces antitumor immunity.靶向敲除髓系细胞中的 PD-1 可诱导抗肿瘤免疫。
Sci Immunol. 2020 Jan 3;5(43). doi: 10.1126/sciimmunol.aay1863.

与 CD4 和 CD8 T 细胞共生的细胞毒性巨噬细胞在 NOD 小鼠中阻断 PD-1 后会导致急性糖尿病。

Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice.

机构信息

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110.

Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110

出版信息

Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31319-31330. doi: 10.1073/pnas.2019743117. Epub 2020 Nov 23.

DOI:10.1073/pnas.2019743117
PMID:33229539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7733808/
Abstract

Autoimmune diabetes is one of the complications resulting from checkpoint blockade immunotherapy in cancer patients, yet the underlying mechanisms for such an adverse effect are not well understood. Leveraging the diabetes-susceptible nonobese diabetic (NOD) mouse model, we phenocopy the diabetes progression induced by programmed death 1 (PD-1)/PD-L1 blockade and identify a cascade of highly interdependent cellular interactions involving diabetogenic CD4 and CD8 T cells and macrophages. We demonstrate that exhausted CD8 T cells are the major cells that respond to PD-1 blockade producing high levels of IFN-γ. Most importantly, the activated T cells lead to the recruitment of monocyte-derived macrophages that become highly activated when responding to IFN-γ. These macrophages acquire cytocidal activity against β-cells via nitric oxide and induce autoimmune diabetes. Collectively, the data in this study reveal a critical role of macrophages in the PD-1 blockade-induced diabetogenesis, providing new insights for the understanding of checkpoint blockade immunotherapy in cancer and infectious diseases.

摘要

自身免疫性糖尿病是癌症患者接受检查点阻断免疫疗法后的并发症之一,但这种不良反应的潜在机制尚不清楚。利用易患糖尿病的非肥胖型糖尿病 (NOD) 小鼠模型,我们模拟了程序性死亡 1 (PD-1)/PD-L1 阻断诱导的糖尿病进展,并确定了一系列高度相互依存的细胞相互作用,涉及致糖尿病的 CD4 和 CD8 T 细胞和巨噬细胞。我们证明,耗竭的 CD8 T 细胞是对 PD-1 阻断产生高水平 IFN-γ 的主要反应细胞。最重要的是,活化的 T 细胞导致单核细胞衍生的巨噬细胞募集,这些巨噬细胞在响应 IFN-γ时会高度激活。这些巨噬细胞通过一氧化氮获得针对β细胞的细胞毒性活性,并诱导自身免疫性糖尿病。总的来说,本研究中的数据揭示了巨噬细胞在 PD-1 阻断诱导的糖尿病发病机制中的关键作用,为理解癌症和传染病中的检查点阻断免疫疗法提供了新的见解。